Research News on Hormonal Therapy
-
Tamoxifen Plus Removing Ovaries Improves Survival for Premenopausal Women
Removing the ovaries and taking tamoxifen after breast cancer surgery had benefits for premenopausal women shows a new study done in Vietnam and China.
-
Tamoxifen and Chemo Reduce Risk of New, Second Cancer
Tamoxifen and chemotherapy reduce the risk of developing a new, second breast cancer in the other breast.
-
Arimidex More Effective Than Tamoxifen for Postmenopausal Women
Another year of results from the ATAC trial continues to show that Arimidex has more benefits than tamoxifen for post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.
-
Postmenopausal Women Benefit from Longer Hormonal Therapy
Taking Arimidex for 3 years after 5 years of tamoxifen reduced the risk of the cancer coming back in women diagnosed with hormone-receptor-positive breast cancer.
-
Different Hormonal Therapies Cause Different Side Effects
Hormonal therapy medicines used to reduce the risk of recurrence have different side effects.
-
Chemotherapy and Aromatase Inhibitors Can Cause Bone Loss
A new study provides more evidence that bone loss is a significant risk for women who receive chemotherapy and/or an aromatase inhibitor to treat breast cancer.
-
Women Stop Taking Hormonal Therapy Too Soon Because of Side Effects
Side effects cause many women to stop taking hormonal therapy medicine earlier than prescribed a new study reports.
-
Hormonal Therapy Medicines Have Improved Survival
Hormone-receptor-positive breast cancer survival rates have increased faster than survival rates for hormone-receptor-negative breast cancer.
-
Tamoxifen Plus Chemo Boosts Survival
Hormonal therapy and chemotherapy boosts survival for women with early breast cancer.
-
Age Affects Treatment Side Effects
Side effects of breast cancer treatment can vary with age.
